Summary:
Clinical Research of Central Florida is conducting a research study to evaluate the efficacy of repeat doses of ALD403 administered intravenously compared to placebo in patients with Frequent Episodic Migraines.
Qualified Participants Must:
• Be between 18 and 75 years of age
•
Have between 4-14 migraines per month
Qualified Participants May Receive:
Study related care and procedures such as lab work and physicals performed by a board certified physician and compensation for time and travel expenses.